...
首页> 外文期刊>Diseases of the Esophagus >Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up
【24h】

Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up

机译:临时自扩张金属支架和充气扩张术治疗al门失弛缓症:一项长期随访的前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The present study compares the efficacy of a self-expanding metallic stent (SEMS, diameter of 30?mm) and pneumatic dilation for the long-term clinical treatment of achalasia. A total of 155 patients diagnosed with achalasia were allocated for pneumatic dilation (n= 80, group A) or a temporary, 30-mm diameter SEMS (n= 75, group B). The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4–5 days after placement. Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up observations were performed at 6 months and at 1, 3–5, 5–8, 8–10, and >10 years, postoperatively. Pneumatic dilation and stent placement were technically successful in all of the patients. There were no significant differences in technique success, 30-day mortality, or complications between the two groups. The clinical remission rate in group A was significantly lower than that in group B at 1, 1–3, 3–5, 5–8 and, >10 years (P < 0.05), while the cumulative clinical failure rate in group A (66%, 53/80) was higher than that in group B (92%, 6/75). The mean primary patency in group B was significantly longer than that in group A (4.2 vs 2.1 years, respectively; P < 0.001). A temporary, 30-mm diameter SEMS was associated with a better long-term clinical efficacy in the treatment of patients with achalasia as compared with treatment with pneumatic dilation.
机译:本研究比较了自膨胀金属支架(SEMS,直径为30?mm)和气动扩张术对门失弛缓症的长期临床疗效。总共155名被诊断为al门失弛缓症的患者被分配进行气动扩张(n = 80,A组)或临时性直径30 mm的SEMS(n = 75,B组)。将SEMS放置在荧光镜的引导下,并在放置后4-5天通过胃镜检查将其移除。收集有关临床症状,并发症和长期临床结果的数据,并在术后6个月,1、3–5、5–8、8–10和> 10年进行随访观察。在所有患者中,气动扩张和支架置入在技术上都是成功的。两组之间在技术成功率,30天死亡率或并发症方面无显着差异。在1、1-3、3-5、5-8和> 10年时,A组的临床缓解率显着低于B组(P <0.05),而A组的累积临床失败率( 66%,53/80)高于B组(92%,6/75)。 B组的平均初级通畅时间明显长于A组(分别为4.2年和2.1年; P <0.001)。与气管扩张术相比,直径为30mm的临时性SEMS与门失弛缓症患者的长期临床疗效更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号